Polyrizon anticipates completing the brand development process in alignment with its ongoing clinical and regulatory milestones.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback